Skip to main content
. 2021 May 25;22(11):5569. doi: 10.3390/ijms22115569

Table 1.

Adiponectin receptor agonists related findings in cancer models.

Agonist Cancer Type Cell Line Anticancer Action Pathway Reference
AdipoRon PDAC Panc-1, Mia Paca-2 (human)
Panc.02, P-4313, K-8484 (mouse)
Apoptosis STAT3
ACC
[53]
AsPC-1, Mia Paca-2, BxPC-3, Panc-1 (human) G0/G1 Blockage
Necroptosis
AKT
ERK1/2
p38
AMPK
[60]
Ovarian OVCAR3, OVCAR4, A2780 (human) G0/G1 Blockage
Apoptosis
AMPK [54]
Myeloma Sp2/0-Ag14 and MPC-11 (mouse) Apoptosis
Autophagy
AMPK
ACC
[55]
TNBC MDA-MB-468, MDA-MB-231, LM2 (human) n/a n/a [56]
Osteosarcoma U2OS, MG-63, Saos-2 (human) G0/G1 Blockage ERK1/2 [62]
ADP355 Prostate LNCaP (human) n/a AMPK
mTOR
p53
[82]
TNBC MCF7, MDA-MB-231 (human) n/a AMPK
ERK1/2
STAT3
[81,83]
Myeloid K562 (human) n/a n/a [83]
Glioma LM18 (human) n/a STAT3
AKT
[81]

(n/a) Not Available.